MedPath

Programmed Intermittent Epidural Bolus For Laboring Obstetrical Women

Phase 4
Completed
Conditions
Labor Pain
Interventions
Registration Number
NCT03712735
Lead Sponsor
University of British Columbia
Brief Summary

Comparison of three programmed intermittent epidural bolus (PIEB) pump settings for maintenance of labour analgesia.

Detailed Description

The optimal PIEB and patient controlled epidural administered (PCEA) bolus settings are still unknown. Therefore, in this study, the investigators aim to compare analgesia outcomes both high and low PIEB flow rate settings.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
390
Inclusion Criteria
  • Singleton, vertex presentations at term (37-42 weeks gestational age)
  • </= 5cm cervical dilation at the time of epidural anesthesia request
  • ASA 2-3 patients aged 19 or over who are able to provide informed consent
Read More
Exclusion Criteria
  • Contraindications to neuraxial analgesia or risk factors likely to affect placement or function of the epidural
  • History of hypersensitivity or idiosyncratic reaction to local anesthetics or opioids
  • Current or historical evidence of any significant medical conditions
  • Clinical settings in which continuous epidural infusion may be preferable
  • Risk factors significantly increasing the need for Cesarean delivery
  • Anticipated fetal abnormalities
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group CBupivacaine 0.08% - fentanyl 2mcgBupivacaine 0.08% - fentanyl 2mcg on the following pump settin PIEB flow rate = low; interval = 45 min
Group ABupivacaine 0.08% - fentanyl 2mcgBupivacaine 0.08% - fentanyl 2mcg on the following pump settings: PIEB flow rate = high; interval = 60 min
Group BBupivacaine 0.08% - fentanyl 2mcgBupivacaine 0.08% - fentanyl 2mcg on the following pump settin PIEB flow rate = high; interval = 45 min
Primary Outcome Measures
NameTimeMethod
Breakthrough painDuration of labor with epidural

Proportion of patients in each group who required a provider administered supplemental bolus for breakthrough pain

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

BC Women's Hospital

🇨🇦

Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath